ClinicalTrials.govpublic full text
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
liver transplantation, transplantation immunology, host vs graft reaction, immunosuppressant, graft loss, combination drug therapy, randomized controlled trial, open level method, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858675
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.